TOINV,

The conspiratist in me feels like the BOD  and large insiders are happy that share price and enterprise valuation continues to fall so they can pick more shares on PP on the cheap and cheaper, maybe to see the venture fail  altogether and pick up the IP for pennies on the dollar. However Hepalink average cost sp base has to be over $1.50 and Oristar  converted  their loan at $1.08 so i would think both of them would like to see a much much share price.   DM need to be replaced  IMO as he has  done nothing to support any shareholder value for over 20 years . He has kept lights at best  over the years which is not saying much when you have a first in class drug that has potential to be huge 1 day.